← Back to Clinical Trials
Recruiting NCT07212894

NCT07212894 DemensiaKITA Mobile Health App to Improve Knowledge, Attitude, Practice and Reduce Burden Among Dementia Caregivers in Malaysia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07212894
Status Recruiting
Phase
Sponsor Universiti Teknologi Mara
Condition Dementia
Study Type INTERVENTIONAL
Enrollment 451 participants
Start Date 2025-10-10
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
DemensiaKITA mobile health applicationUsual Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 451 participants in total. It began in 2025-10-10 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Dementia is a growing health concern in Malaysia and places a heavy burden on family members who act as caregivers. Many caregivers struggle with limited knowledge, negative attitudes, and challenges in daily caregiving practices. These issues increase caregiver stress and reduce the quality of care for people living with dementia. The DemensiaKITA mobile health application was developed to support caregivers by providing educational content, self-help tools, and practical guidance. This study will evaluate whether using the DemensiaKITA app can improve caregivers' knowledge, attitudes, and caregiving practices (KAP), as well as reduce caregiver burden. This is a non-randomized controlled trial involving dementia caregivers in Kuala Lumpur and Selangor. Participants in the intervention group will use the DemensiaKITA mobile app for a set period, while the control group will continue with usual support. Outcomes will be measured before and after the intervention using validated questionnaires. The results of this study will provide evidence on the effectiveness of a locally developed mobile health application in supporting dementia caregivers in Malaysia. If successful, this digital approach may be scaled up to improve caregiver support and dementia care in other settings.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18 years and above * Primary informal caregiver of a person living with dementia (family member or household member) * Able to read and understand Malay * Owns a smartphone and is able to use mobile applications * Provides informed consent to participate Exclusion Criteria: * Professional/paid caregivers (e.g., nurses, domestic helpers hired solely for caregiving) * Caregivers of patients with conditions other than dementia * Individuals with severe cognitive or psychiatric illness that limits their ability to participate

Contact & Investigator

Central Contact

Nurulizzah Mahfar, Medical degree

✉ izzahmahfar@gmail.com

📞 0193107344

Principal Investigator

Nurulizzah Mahfar

PRINCIPAL INVESTIGATOR

Universiti Teknologi MARA Sg Buloh Campus

Frequently Asked Questions

Who can join the NCT07212894 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07212894 currently recruiting?

Yes, NCT07212894 is actively recruiting participants. Contact the research team at izzahmahfar@gmail.com for enrollment information.

Where is the NCT07212894 trial being conducted?

This trial is being conducted at Sungai Buloh, Malaysia.

Who is sponsoring the NCT07212894 clinical trial?

NCT07212894 is sponsored by Universiti Teknologi Mara. The principal investigator is Nurulizzah Mahfar at Universiti Teknologi MARA Sg Buloh Campus. The trial plans to enroll 451 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology